Skip to main content
Clinical Trials/NCT03673514
NCT03673514
Completed
N/A

Direct Anterior Versus Posterior Approach for Total Hip Arthroplasty: a Multicentric Prospective Randomized Clinical Study

Hopital du Sacre-Coeur de Montreal0 sites50 target enrollmentFebruary 1, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Total Hip Arthroplasty
Sponsor
Hopital du Sacre-Coeur de Montreal
Enrollment
50
Primary Endpoint
Hospital stay
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Determining the best approach for a total hip arthroplasty (THA) implies that the procedure is kind on soft tissues, with the lowest complication rates, and easily reproducible. Although there have been several attempts to resolve this issue in the last decade, a definitive answer has not been found. Therefore, the investigators performed a prospective study to compare direct anterior versus posterior approach based on (1) hospital stay, (2) functional outcome, (3) pain, (4) implant position (5) complications and (6) surgical time.

Detailed Description

In this multicentric, prospective, randomized clinical trial, 55 total hip arthroplasties were performed on 50 patients between February 2011 and July 2013. Patients meeting the inclusion criteria underwent surgical treatment using the DAA or PA, according to a randomization process. Radiological analysis assessed implant position, limb lengthening, and potential implant related complications. X-rays were performed at subsequent follow-up visits and consisted of an antero-posterior (AP) pelvic X-ray and a lateral projection of the hip. Two independent observers, not involved with patients or surgeries, reviewed all postoperative radiographs independently.Two fellowship-trained surgeons in two separate hospitals performed all procedures. Both surgeons had previously performed over 100 cases with each approach, before initiating this study. Patients underwent either the posterior or direct anterior approach.

Registry
clinicaltrials.gov
Start Date
February 1, 2011
End Date
August 1, 2013
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kevin Moerenhout

Orthopedic Surgeon

Hopital du Sacre-Coeur de Montreal

Eligibility Criteria

Inclusion Criteria

  • primary total hip replacement due to osteoarthrosis or osteonecrosis
  • patients older than 50 years.

Exclusion Criteria

  • inflammatory arthritis,
  • any previous ipsilateral hip surgery
  • suffering from proximal femoral deformity
  • BMI over 40
  • active infection
  • severe contralateral hip disease, muscle contractures or neuromuscular pathology
  • requiring structural bone grafts.

Outcomes

Primary Outcomes

Hospital stay

Time Frame: Between 0 days and 1 month, average of 4 days

Length in days of hospital stay

Secondary Outcomes

  • implant position(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • functional recovery(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • pain assessment: VAS(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • number of patients with per/post surgical complications.(2 weeks, 4 weeks, 3 months, 6 months, 1 year, 2 years and 5 years postoperatively)
  • surgical time(Up to 240 minutes)

Similar Trials